GEHC vs. IDXX: GE HealthCare vs. IDEXX Laboratories Stock Comparison

Company Profile

GE HealthCare (GEHC) and IDEXX Laboratories (IDXX) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

IDEXX Laboratories (IDXX) has more than two decades of public-market history since June 21, 1991, whereas GE HealthCare (GEHC) listed on December 15, 2022 and has a much shorter record to draw on.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

IDEXX Laboratories (IDXX) has an aggressive beta of 1.44, indicating higher sensitivity to broad-market moves, while GE HealthCare (GEHC) is defensive at 0.69 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both companies show strong equity returns, but IDEXX Laboratories (IDXX) at 68.93% is the standout with ROE above its industry range; GE HealthCare (GEHC) at 20.01% also sits in the top quartile.

For every dollar of sales, both GE HealthCare (GEHC) at 9.95% and IDEXX Laboratories (IDXX) at 25.36% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both GE HealthCare (GEHC) at 15.33% and IDEXX Laboratories (IDXX) at 33.14% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Both GE HealthCare (GEHC) at 4.84% and IDEXX Laboratories (IDXX) at 10.42% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Both GE HealthCare (GEHC) at 4.84% and IDEXX Laboratories (IDXX) at 22.59% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Growth Metrics

Financial Strength

Both GE HealthCare (GEHC) at 1.30 and IDEXX Laboratories (IDXX) at 1.19 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

Both GE HealthCare (GEHC) at 0.88 and IDEXX Laboratories (IDXX) at 0.52 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

IDEXX Laboratories (IDXX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile GE HealthCare (GEHC) reports a yield of 0.17%, ranking against industry peers normally.

IDEXX Laboratories (IDXX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile GE HealthCare (GEHC) reports a payout of 2.96%, ranking against industry peers normally.

Dividend Metrics

Valuation

GE HealthCare (GEHC) at 17.42 sits in the cheaper P/E ratio quartile, while IDEXX Laboratories (IDXX) at 45.56 is closer to its industry’s usual earnings multiple — a discount for GEHC, though growth and earnings durability still matter.

GE HealthCare (GEHC) at 1.72 prices around its industry’s typical P/S ratio, while IDEXX Laboratories (IDXX) at 11.42 clears its benchmark range — IDXX looks notably rich on sales.

GE HealthCare (GEHC) at 3.21 sits near its industry’s typical P/B ratio, while IDEXX Laboratories (IDXX) at 28.50 prices above its benchmark range — IDXX looks rich relative to book.

Valuation Metrics